SCHEMBL5042674

SCHEMBL5042674

COC(=O)/C(=C/c1ccc(OCCc2nc(-c3ccccc3)oc2C)c2ccsc12)OC

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.63
PPARA Q07869 20/20 0.63
PPARD Q03181 6/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5042682 1.00 PPARG (0.63) PPARGPPARAPPARD
SCHEMBL5042678 1.00 PPARG (0.63) PPARGPPARAPPARD
SCHEMBL31095006 0.94 PPARG (0.56) PPARGPPARAPPARD
SCHEMBL482387 0.94 PPARG (0.64) PPARGPPARAPPARD
SCHEMBL482389 0.94 PPARG (0.64) PPARGPPARAPPARD
SCHEMBL482386 0.94 PPARG (0.64) PPARGPPARAPPARD
SCHEMBL31094998 0.94 PPARG (0.55) PPARGPPARAPPARD
SCHEMBL14206871 0.93 PPARG (0.63) PPARGPPARAPPARD
SCHEMBL31095028 0.93 PPARG (0.56) PPARGPPARAPPARD
SCHEMBL31095009 0.90 PPARG (0.51) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365207-B2 Process for the production of chiral propionic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2008-04-29 US claimed
EP-1670792-B1 PROCESS FOR THE PREPARATION OF CHIRAL PROPIONIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2007-12-19 EP claimed
US-20070249842-A1 Process for the production of chiral propionic acid derivatives PUENTENER KURT 2007-10-25 US claimed
US-7262303-B2 Process for the production of chiral propionic acid derivatives HOFFMAN-LA ROCHE INC. (US) 2007-08-28 US claimed
JP-2007506800-A 2007-03-22 JP claimed
EP-1670792-A1 PROCESS FOR THE PREPARATION OF CHIRAL PROPIONIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-06-21 EP claimed
WO-2005030764-A1 PROCESS FOR THE PREPARATION OF CHIRAL PROPIONIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-04-07 WO claimed
US-20050070714-A1 Process for the production of chiral propionic acid derivatives HOFFMANN-LA ROCHE INC. 2005-03-31 US claimed
US-7365207-B2 Process for the production of chiral propionic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2008-04-29 US disclosed
EP-1670792-B1 PROCESS FOR THE PREPARATION OF CHIRAL PROPIONIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2007-12-19 EP disclosed
US-20070249842-A1 Process for the production of chiral propionic acid derivatives PUENTENER KURT 2007-10-25 US disclosed
US-7262303-B2 Process for the production of chiral propionic acid derivatives HOFFMAN-LA ROCHE INC. (US) 2007-08-28 US disclosed
EP-1670792-A1 PROCESS FOR THE PREPARATION OF CHIRAL PROPIONIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-06-21 EP disclosed
WO-2005030764-A1 PROCESS FOR THE PREPARATION OF CHIRAL PROPIONIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-04-07 WO disclosed
US-20050070714-A1 Process for the production of chiral propionic acid derivatives HOFFMANN-LA ROCHE INC. 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070714-A1 Process for the production of chiral propionic acid derivatives HRH4, HRH3, HRH1 PPARG 805/4885PPARA 499/4885PPARD 460/4885
US-20070249842-A1 Process for the production of chiral propionic acid derivatives HRH4, HRH3, HRH1 PPARG 805/4885PPARA 499/4885PPARD 460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.